Addex Therapeutics (ADXN) Cash & Equivalents (2017 - 2026)
Addex Therapeutics (ADXN) recorded Cash & Equivalents of $970,853 in Q2 2026, down 65.1% from $2.78 million a year earlier and down 18.7% from the prior quarter.
Powered by 
Analysis
Addex Therapeutics (ADXN) Cash & Equivalents (2017 - 2026) Analysis & Trends
At the end of FY2025, Addex Therapeutics reported Cash & Equivalents of $2.05 million, down 46.0% from FY2024.
- Annual Cash & Equivalents has declined for six straight years, with a five-year compound annual growth rate of -43.3% (FY2020 to FY2025).
- Across earlier years, Cash & Equivalents came in at $3.8 million in FY2024 (-51.6%), $7.84 million in FY2023 (-63.1%), $21.26 million in FY2022 (-4.3%) and $22.22 million in FY2021 (-36.3%).
- The Q2 2026 figure is the lowest quarterly Cash & Equivalents in data going back to Q4 2017.
- On a year-over-year basis, Cash & Equivalents has declined for five consecutive quarters, with an average decline of 26.0% over the last eight quarters.
- Peak year-over-year performance for Cash & Equivalents in the last five years was growth of 68.5% in Q1 2025, against a decline of 69.2% in Q1 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $1.19 million (Q1 2026), $2.05 million (Q4 2025) and $2.73 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Addex Therapeutics | 2.75 Mn | 2.75 Mn | - | 970,853.39 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 970,853.39 |
| Mar 31, 2026 | 1.19 Mn |
| Dec 31, 2025 | 2.05 Mn |
| Sep 30, 2025 | 2.73 Mn |
| Jun 30, 2025 | 2.78 Mn |
| Mar 31, 2025 | 3.14 Mn |
| Dec 31, 2024 | 3.81 Mn |
| Sep 30, 2024 | 3.87 Mn |
| Jun 30, 2024 | 4.19 Mn |
| Mar 31, 2024 | 1.86 Mn |
| Dec 31, 2023 | 4.36 Mn |
| Sep 30, 2023 | 5.38 Mn |
| Jun 30, 2023 | 7.97 Mn |
| Mar 31, 2023 | 6.05 Mn |
| Dec 31, 2022 | 7.22 Mn |
| Sep 30, 2022 | 10.79 Mn |
| Jun 30, 2022 | 9.15 Mn |
| Mar 31, 2022 | 16.12 Mn |
| Dec 31, 2021 | 22.22 Mn |
| Sep 30, 2021 | 16.87 Mn |
API Access
Addex Therapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ADXN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "ADXN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ADXN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();